Integrated Diagnostics Holdings plc
IDGXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $13 | $7 | $9 | $12 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $13 | $7 | $10 | $12 |
| Revenue | $6 | $4 | $4 | $5 |
| % Growth | 38.7% | 14.4% | -31% | – |
| Gross Profit | $2 | $2 | $1 | $3 |
| % Margin | 38.1% | 37% | 40.6% | 53.7% |
| EBITDA | $2 | $1 | $1 | $3 |
| % Margin | 36.6% | 31.1% | 35.9% | 49.2% |
| Net Income | $1 | $1 | $1 | $1 |
| % Margin | 18.8% | 12.4% | 15% | 27% |
| EPS Diluted | 1.82 | 0.85 | 0.9 | 2.35 |
| % Growth | 114.1% | -5.6% | -61.7% | – |
| Operating Cash Flow | $2 | $1 | $0 | $2 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | $0 | -$0 | $2 |